[1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation

[1]  Guisheng Zhang,et al.  Recombinant DENV 2 NS5: An effective antigen for diagnosis of DENV infection. , 2019, Journal of virological methods.

[2]  Kutty Selva Nandakumar,et al.  Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infection. , 2018, Journal of pharmacological sciences.

[3]  T. Rungrotmongkol,et al.  Cardol triene inhibits dengue infectivity by targeting kl loops and preventing envelope fusion , 2018, Scientific Reports.

[4]  N. Syed,et al.  Dengvaxia controversy: impact on vaccine hesitancy , 2018, Journal of global health.

[5]  H. Margolis,et al.  Estimating dengue under-reporting in Puerto Rico using a multiplier model , 2018, PLoS neglected tropical diseases.

[6]  Daniel L. Vera,et al.  An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection , 2018, Stem cell reports.

[7]  Binbin Jin,et al.  piRNA Profiling of Dengue Virus Type 2-Infected Asian Tiger Mosquito and Midgut Tissues , 2018, Viruses.

[8]  Kutty Selva Nandakumar,et al.  Tatanan A from the Acorus calamus L. root inhibited dengue virus proliferation and infections. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[9]  Kutty Selva Nandakumar,et al.  Inhibition of dengue viral infection by diasarone‐I is associated with 2’O methyltransferase of NS5 , 2018, European journal of pharmacology.

[10]  Yong-Ha Park,et al.  Prevention and Control Strategies to Counter Dengue Virus Infection , 2017, Front. Cell. Infect. Microbiol..

[11]  N. Vasilakis,et al.  Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond , 2017, Nature Reviews Drug Discovery.

[12]  S. Hsieh,et al.  Pharmacological intervention for dengue virus infection. , 2017, Biochemical pharmacology.

[13]  M. Bolognesi,et al.  Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor. , 2016, Antiviral research.

[14]  E. Damonte,et al.  Antiviral activity of natural and synthetic β-carbolines against dengue virus. , 2016, Antiviral research.

[15]  Hongping Dong,et al.  Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling , 2016, PLoS pathogens.

[16]  J. Chen,et al.  Functional properties of DENV EDIII‑reactive antibodies in human DENV‑1‑infected sera and rabbit antiserum to EDIII. , 2016, Molecular medicine reports.

[17]  S. Tajima,et al.  Novel antiviral activity of bromocriptine against dengue virus replication. , 2016, Antiviral research.

[18]  Mihaela Puiu,et al.  SPR and SPR Imaging: Recent Trends in Developing Nanodevices for Detection and Real-Time Monitoring of Biomolecular Events , 2016, Sensors.

[19]  Uma S. Kamaraj,et al.  Molecular determinants of plaque size as an indicator of dengue virus attenuation , 2016, Scientific Reports.

[20]  Paul W Smith,et al.  Discovery of Potent Non-Nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from a Fragment Hit Using Structure-Based Drug Design. , 2016, Journal of medicinal chemistry.

[21]  Paul W Smith,et al.  A Conserved Pocket in the Dengue Virus Polymerase Identified through Fragment-based Screening* , 2016, The Journal of Biological Chemistry.

[22]  M. Wainberg,et al.  Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase , 2015, Antimicrobial Agents and Chemotherapy.

[23]  P. Shi,et al.  The dengue virus NS5 protein as a target for drug discovery. , 2015, Antiviral research.

[24]  Neerja Kaushik-Basu,et al.  Characterization of the activity of 2'-C-methylcytidine against dengue virus replication. , 2015, Antiviral research.

[25]  Jianfeng Dai,et al.  DEAD-box RNA helicase DDX3X inhibits DENV replication via regulating type one interferon pathway. , 2015, Biochemical and biophysical research communications.

[26]  A. García-Sastre,et al.  The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. , 2014, Cell host & microbe.

[27]  Hongmin Li,et al.  The flavivirus protease as a target for drug discovery , 2013, Virologica Sinica.

[28]  David Beer,et al.  Ten years of dengue drug discovery: progress and prospects. , 2013, Antiviral research.

[29]  Ramyavardhanee Chandrasekaran,et al.  A Crystal Structure of the Dengue Virus Non-structural Protein 5 (NS5) Polymerase Delineates Interdomain Amino Acid Residues That Enhance Its Thermostability and de Novo Initiation Activities* , 2013, The Journal of Biological Chemistry.

[30]  Jian Wang,et al.  Severe dengue due to secondary DENV-1 infection in Mainland China. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[31]  J. An,et al.  Recent Advances in DENV Receptors , 2013, TheScientificWorldJournal.

[32]  Wei Chen,et al.  Identification and characterization of a 43 kDa actin protein involved in the DENV-2 binding and infection of ECV304 cells. , 2013, Microbes and infection.

[33]  J. MacMicking.  Interferon-inducible effector mechanisms in cell-autonomous immunity , 2012, Nature Reviews Immunology.

[34]  Jianfeng Dai,et al.  ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro , 2011, Virology Journal.

[35]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[36]  A. Gamarnik,et al.  The F1 Motif of Dengue Virus Polymerase NS5 Is Involved in Promoter-Dependent RNA Synthesis , 2011, Journal of Virology.

[37]  Kong-Peng Lam,et al.  RIG-I, MDA5 and TLR3 Synergistically Play an Important Role in Restriction of Dengue Virus Infection , 2011, PLoS neglected tropical diseases.

[38]  K. Boonnak,et al.  Cell Type Specificity and Host Genetic Polymorphisms Influence Antibody-Dependent Enhancement of Dengue Virus Infection , 2010, Journal of Virology.

[39]  Xueli Zheng,et al.  [Expression, purification and identification of the domain III of DENV II envelop protein in Escherichia coli]. , 2010, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[40]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[41]  H. Teng,et al.  Emergency vector control in a DENV-2 outbreak in 2002 in Pingtung City, Pingtung County, Taiwan. , 2007, Japanese journal of infectious diseases.

[42]  P. Shi,et al.  Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design. , 2018, Advances in experimental medicine and biology.

[43]  Thijs Beuming,et al.  Investigating Protein-Peptide Interactions Using the Schrödinger Computational Suite. , 2017, Methods in molecular biology.